Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling
Shanqi Guo, Yangyi Zhang, Shuo Wang, et al.
Toxicology Letters (2021) Vol. 348, pp. 50-58
Closed Access | Times Cited: 21

Showing 21 citing articles:

Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
Qiushi Zhao, Xingyu Lin, Guan Wang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 81
Lipid Metabolism and Cancer
Hui Cheng, Meng Wang, Jingjing Su, et al.
Life (2022) Vol. 12, Iss. 6, pp. 784-784
Open Access | Times Cited: 65
Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer
Miaomiao Huo, Jingyao Zhang, Wei Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
Interactions of antimony with biomolecules and its effects on human health
Ziyang Lai, Mengchang He, Chunye Lin, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 233, pp. 113317-113317
Open Access | Times Cited: 55
Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation
Mojdeh Amini Faskhoudi, Pejman Molaei, Mehrdokht Sadrkhanloo, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153851-153851
Closed Access | Times Cited: 26
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
LncRNAs‐circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers
Shanshan Liu, Benzheng Jiao, Hongguang Zhao, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR‐7/m‐TOR/SREBP1 pathway on prostate cancer
Wenjing Xu, Jin Ding, Bonan Li, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 438-456
Closed Access | Times Cited: 20
A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Pathology - Research and Practice (2022) Vol. 231, pp. 153800-153800
Closed Access | Times Cited: 19
MiR-27a-5p inhibits malignant progression of differentiated thyroid cancer by directly affecting the miR-27a-5p/SREBP1 axis
Zilan Xie, Jianqiu Liu, Jiating Zhou, et al.
Journal of Endocrinological Investigation (2025)
Closed Access
Short-term exposure to antimony induces hepatotoxicity and metabolic remodeling in rats
Wen Gu, Ruifang Pang, Yuanyuan Chen, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 256, pp. 114852-114852
Open Access | Times Cited: 6
Al-MPS Obstructs EMT in Breast Cancer by Inhibiting Lipid Metabolism via miR-215-5p/SREBP1
Chenlu L Wu, Lili Xu, Jing Peng, et al.
Endocrinology (2022) Vol. 163, Iss. 5
Open Access | Times Cited: 10
Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
Jyotirmayee Talapatra, Mamatha M. Reddy
Cancers (2023) Vol. 15, Iss. 7, pp. 2144-2144
Open Access | Times Cited: 5
lncRNA PCA3 Suppressed Carotid Artery Stenosis and Vascular Smooth Muscle Cell Function via Negatively Modulating the miR-124-3p/ITGB1 Axis
Guosheng Li, Qiang Chen
Clinical and Applied Thrombosis/Hemostasis (2023) Vol. 29
Open Access | Times Cited: 4
Long non‑coding RNAs, lipid metabolism and cancer (Review)
Zhendong Zhang, Xin-Rui Hou, Xiao‐Lan Cao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 2
N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer
Yingke Liang, Wenjun Yin, Zhouda Cai, et al.
Human Genetics (2023) Vol. 143, Iss. 7, pp. 857-874
Closed Access | Times Cited: 2
MicroRNA-mediated reprogramming of glucose, fatty acid and amino acid metabolism in cancer
Jie Ding, Yifan Wen, Xu Yuan, et al.
Genome Instability & Disease (2022) Vol. 4, Iss. 2, pp. 47-69
Closed Access | Times Cited: 3
The up-regulation of TGF-beta1 by miRNA-132-3p/WT1 is involved in inducing leukemia cells to differentiate into macrophages
Zhimin Wang, Chaozhe Wang, Danfeng Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
MiR-27a-5p inhibits malignant progression of differentiated thyroid cancer through SREBP1 and is associated with thyrotropin suppressive therapy
Zilan Xie, Jianqiu Liu, Jiating Zhou, et al.
Research Square (Research Square) (2024)
Open Access
The Role of miR-132-3p in Inhibiting the Proliferation, Invasion and Metastasis of Colon Cancer by Targeted Regulation of PDGF
Chaobin Li, Kemei Lu, Cuicui Lang, et al.
Journal of Biomedical Nanotechnology (2024) Vol. 20, Iss. 9, pp. 1416-1426
Closed Access
Long noncoding RNA in human cancers: to be or not to be, that is the question
Sonia Cinque, Marianna Aprile, Valerio Costa, et al.
Elsevier eBooks (2023), pp. 109-127
Closed Access | Times Cited: 1
Page 1

Scroll to top